Our previous results show that inhibition of their actions by the administration of an IL-1 receptor antagonist (IL-1RA) and IL-18 binding protein (IL-18BP) alleviates the symptoms of neuropathic pain and enhances the analgesic effect of opioids on neuropathy [60,70]. This evidence concerns the gene IL18BP and neuropathy.